Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bcl-2-associated agonist of cell death (BAD) is a pro-apoptotic protein belonging to the Bcl-2 family. It plays a crucial role in regulating apoptosis by interacting with anti-apoptotic members of the Bcl-2 family, such as Bcl-2 and Bcl-xL. BAD's activity is modulated through phosphorylation, which affects its ability to induce cell death. It is involved in various diseases, including cancer and neurodegenerative conditions[1][5][7].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bcl-2-associated agonist of cell death (BAD).